Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases
- 1 July 2002
- journal article
- case report
- Published by Wiley in Addiction Biology
- Vol. 7 (3) , 321-323
- https://doi.org/10.1080/13556210220139541
Abstract
The maximum dose of heroin that is blocked by customary doses of oral naltrexone (NTX) and its active metabolite 6-beta-naltrexol (6BNT) is unknown, particularly at trough serum levels which show much interindividual variation and can be low. NTX has only once been tested formally against opiate equivalents of more than 25 mg of diamorphine. Increasing interest in long-acting implantable NTX preparations makes it important to have objective information about blocking activity at various blood levels of NTX and 6BNT. Two cases are described in which NTX and 6BNT levels as low as 2.8 and 9.0 ng/ml, respectively, were sufficient to block doses of pure diamorphine as high as 500 mg.Keywords
This publication has 9 references indexed in Scilit:
- 24‐Hour opiate detoxification and antagonist induction at home–the ‘Asturian method’: a report on 1368 proceduresAddiction Biology, 2002
- Serum 6-Beta-Naltrexol Levels Are Related to Alcohol Responses in Heavy DrinkersAlcohol, Clinical and Experimental Research, 2000
- Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addictsDrug and Alcohol Dependence, 1998
- Naltrexone pharmacotherapy for opioid dependent federal probationersJournal of Substance Abuse Treatment, 1997
- The Singapore naltrexone community-based project for heroin addicts compared with drugfree community-based program: the first cohortJournal of Clinical Forensic Medicine, 1996
- Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addictsDrug and Alcohol Dependence, 1994
- Naltrexone: Disposition, metabolism, and effects after acute and chronic dosingClinical Pharmacology & Therapeutics, 1976
- Studies of EN-1639A (Naltrexone): A New Narcotic AntagonistAmerican Journal of Psychiatry, 1974
- A Sustained Release Depot for Narcotic AntagonistsArchives of General Psychiatry, 1974